Liver Cancer Vaccine Effective In Mice

Antigen Engineering has allowed scientists to formulate a cancer vaccine that is effective in preventing liver cancer in mice. By modifying Alpha-Fetoprotien (AFP), an antigen for liver cancer, Dr. Yukai He was able to make it so that the immune system would still recognise it, but would keep the protein expressed by cancer cells. AFP is expressed during development and …

Global Partners SillaJen, Transgene and Lee’s Pharmaceutical Confirm Clinical Development Plan for Pexa-Vec

Enrollment of Phase 3 study in first-line advanced liver cancer expected to begin by mid-2015 – To initiate several additional Phase 1/2 trials during 2014 Marchc 26, 2014 Transgene SA, Lee’s Pharmaceutical and SillaJen today unveiled their late-stage clinical development plan for Pexa-Vec oncolytic immunotherapy. The companies plan to initiate a global Phase 3 study in the first-line treatment of advanced …